Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$2.49 - $11.85 $5,229 - $24,885
2,100 New
2,100 $5,000
Q3 2022

Nov 07, 2022

BUY
$11.19 - $17.89 $54,596 - $87,285
4,879 New
4,879 $57,000
Q2 2022

Aug 09, 2022

SELL
$9.03 - $21.55 $34,521 - $82,385
-3,823 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$15.0 - $22.83 $57,345 - $87,279
3,823 New
3,823 $79,000
Q1 2021

May 14, 2021

SELL
$39.04 - $64.6 $11,712 - $19,380
-300 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$42.46 - $56.58 $16,984 - $22,632
-400 Reduced 57.14%
300 $13,000
Q3 2020

Nov 16, 2020

BUY
$37.44 - $64.63 $26,208 - $45,241
700 New
700 $30,000

Others Institutions Holding BTAI

About BioXcel Therapeutics, Inc.


  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $14.3M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.